Keyword: GlaxoSmithKline

In its second year on the top job, Walmsley earned about half of what AstraZeneca CEO Pascal Soriot received in 2018.

ViiV has already shown a two-drug HIV regimen can compete with its three-drug rivals. Now it has data showing it can do it with once-monthly dosing.

GSK's Tesaro has partnered with actor Scott Foley for the newest PSA in its initiative to raise awareness of ovarian cancer maintenance treatment.

GSK sells Indian vaccine subsidiary to Bharat; Dr. Reddy's rides a turbulent week; Sandoz sells more U.S. generics.

After the buy, Bharat Biotech will be able to make 25 million doses of rabies vaccine each year, its chairman said.

Mylan has set its list price for its Advair copy at a 70% discount to the brand. But the move may not be as dramatic as it seems.

GSK expects sales of its pharma business to decline in 2019 thanks to the launch of Mylan's generic Advair.

Here is some other vaccine news of note for the week.

As Leerink Partners analyst Ami Fadia put it in a note to clients Wednesday afternoon, Godot is finally here. And that Godot is generic Advair.